Nutex Health Inc. (NASDAQ: NUTX) shares leapt 20.97% in after-hours trading on Tuesday, reaching $120.
Have a look at the existing rate of NUTX stock here.
The stock closed Tuesday’s routine session down 4.57% at $99.20, according to Benzinga Pro information.
Q2 2025 Outcomes Drive Rally
The physician-led health care business reported second-quarter and year-to-date monetary outcomes.
| Duration | 2025 Income ( USD million) |
2024 Income ( USD million) |
YoY Modification (%) |
|---|---|---|---|
| 6 months ended June 30 | 455.8 | 143.5 | 217.5 |
| 2nd quarter | 244.0 | 76.1 | 220.7 |
Success Metrics
For the 6 months ended June 30, Nutex Health reported adjusted revenues before interest, taxes, devaluation, and amortization (EBITDA) of $144.4 million, up from $6.4 million a year previously. Running earnings increased $107.6 million to $114.3 million. The business published earnings of $3.5 million and created $78.2 million in net money from running activities in the very first half of 2025.
Since June 30, Nutex Health had $96.7 million in money and money equivalents and overall properties of $841 million.
See Likewise: Walmart Q3 Sneak Peek: Merchant ‘Well-Positioned To Win,’ Expert Lays Out Bull Vs. Bear Case
Share Repurchase Program
The board likewise licensed a $25 million stock buyback program on Aug. 14, targeted at increasing investor worth and balancing out dilution from stock payment commitments.
Management Commentary
CEO Tom Vo stated, “The Business thinks its shares are presently underestimated,” while primary monetary officer Jon Bates highlighted the business’s “record high money balance of $96.7 million.”
The health care shipment system runs in 24 micro-hospitals throughout 11 states.
Stock Efficiency
The stock of the Texas-based business has actually risen 253.02% over the previous year and 185.71% year-to-date, though it has actually fallen 43.7% over the last 6 months.
It has actually traded in between $27.29 and $184.28 over the previous year, with a market capitalization of $551.07 million.
With a strong Momentum in the 95th percentile, Benzinga’s Edge Stock Rankings show that NUTX is experiencing short-term debt consolidation together with medium and long-lasting upward motion. Know how its momentum lines up with other popular names.
Read Next:
Picture Courtesy: BEST-BACKGROUNDS on Shutterstock.com
Disclaimer: This material was partly produced with the assistance of AI tools and was examined and released by Benzinga editors.